COMPOSITION
White - cream, sterile, oily suspension Betaseft 2.5% Injectable Suspension contains 25 mg cefquinome equivalent cefquinome sulfate per ml and 10 mg benzyl alcohol (E1519) as preservative.
INDICATIONS FOR USE
It is used in the treatment of infections caused by Gram-positive and Gram-negative microorganisms susceptible to cefquinome in cattle. It is administered for the treatment of the following diseases:
- Respiratory system disease caused by Pasteurella multocida and M. Haemolytica
- Digital dermatitis, infectious bulbar necrosis and acute interdigital necrobacillosis (foot caries)
- Acute E. coli mastitis with systemic symptoms
- E. coli septicemia in calves.
ADMINISTRATION ROUTES AND AMOUNTS
It is administered intramuscularly (IM) in the following doses and times unless otherwise recommended by the veterinarian.
Studies have indicated that it is appropriate to perform second and sequential injections at different injection sites. The preferred site of injection is the middle neck muscle tissue. Shake the bottle thoroughly before use. In order to ensure the correct dose, body weight should be calculated as well as possible to avoid overdose. Dry and sterile needles and syringes should be used during application. An appropriately graded syringe should be used to allow accurate delivery of the required dose volume.
WITHDRAWAL PERIOD(S)
Drug Residue Purification Time: Cattle should not be sent to slaughter during treatment and 5 days after the last drug administration. Cow milk obtained during the treatment and 1 day (2 milking) following the last drug application should not be offered to human consumption.
MARKETING PACKAGING
It is offered in 50 ml and 100 ml type II colorless glass vials sealed with red bromobutyl rubber stopper and green aluminum flip-off lid in cardboard box.
